Navigation Links
Gene Therapy Offers Hope Against Inherited Blindness
Date:8/12/2009

Injection under retina may allow increased light sensitivity, research suggests

WEDNESDAY, Aug. 12 (HealthDay News) -- Gene therapy for an inherited form of blindness shows promise, a U.S. study shows.

The phase I trial included three patients, aged 22, 24 and 25, with a form of Leber congenital amaurosis caused by mutations in the RPE65 gene. Proper functioning of this gene is required for the production of a retina-specific form of vitamin A that's required for light-sensitive photoreceptor cells to function.

In the study, researchers injected healthy copies of the RPE65 gene under the retina in the eyes of the participants, who'd been legally blind since birth. One year after treatment, the patients could detect very dim lights that they weren't able to see prior to treatment. The results provide evidence that the newly introduced RPE65 gene is functional and is increasing the light sensitivity of the retina, according to the researchers.

The findings appear in the August online edition of Human Gene Therapy and in a letter to the editor in the Aug. 13 issue of the New England Journal of Medicine.

"At one year, we have now found that the RPE65 gene therapy appears to be safe and leads to a stable visual improvement in the patients studied. We are cautiously optimistic about these results and look forward to additional reports that address the key issues of safety and effectiveness," study author Artur V. Cideciyan, a research associate professor of ophthalmology at the University of Pennsylvania, said in a news release from the National Eye Institute.

"These results are very significant because they represent one of the first steps toward the clinical use of gene therapy for an inherited form of blindness. I anticipate that it is only a matter of time before similar techniques will be applied to other genetic diseases affecting vision," Dr. Paul A. Sieving, director of the U.S.
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. ProCure and INTEGRIS Choose Elekta for Proton Therapy and Cancer Centers
2. Folk Medicine Therapy May Prevent Alcoholic Relapse
3. Computer system improves pain therapy for cancer patients
4. Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective
5. APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services
6. Hollins Communications Research Institute Announces More Stuttering Therapy Scholarships
7. In U.S., No Comeback Seen for Hormone Therapy
8. The Sloane Clinic pioneers Ultherapy in Singapore
9. State Regulation of Massage Therapy Will Improve Public Health, Safety
10. Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients
11. Omaha School of Massage Therapy Adds Healthcare Programs, Joins Herzing University, and Changes Name
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy Offers Hope Against Inherited Blindness 
Gene Therapy Offers Hope Against Inherited Blindness
Breaking Medicine Technology:St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 1Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 3Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 4Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 5Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 6Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 7Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 8Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 9Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 10Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 11Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 12Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 13Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 14Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 15Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 16MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 1MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 2MarketsandMarkets 3A Global Stem Cell and Advanced Technologies Market Worth US 24 88 3 Billion By 2014 14699 3Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 1Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 2Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 3